XOMA Corporation (XOMA)
NASDAQ: XOMA · IEX Real-Time Price · USD
25.48
+0.89 (3.62%)
At close: Apr 19, 2024, 4:00 PM
25.51
+0.03 (0.12%)
After-hours: Apr 19, 2024, 4:02 PM EDT
XOMA Corporation Market Cap
XOMA Corporation has a market cap or net worth of $296.23 million as of April 19, 2024. Its market cap has increased by 26.75% in one year.
Market Cap
296.23M
Enterprise Value
267.06M
1-Year Change
26.75%
Ranking
Category
Stock Price
$25.48
Market Cap Chart
Since December 1, 1998, XOMA Corporation's market cap has increased from $151.40M to $296.23M, an increase of 95.66%. That is a compound annual growth rate of 2.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 296.20M | 3.60% |
Apr 18, 2024 | 285.90M | 1.42% |
Apr 17, 2024 | 281.90M | -0.53% |
Apr 16, 2024 | 283.40M | 0.14% |
Apr 15, 2024 | 283.00M | -5.82% |
Apr 12, 2024 | 300.50M | -1.35% |
Apr 11, 2024 | 304.60M | 1.63% |
Apr 10, 2024 | 299.70M | 0.67% |
Apr 9, 2024 | 297.70M | 1.47% |
Apr 8, 2024 | 293.40M | -0.41% |
Apr 5, 2024 | 294.60M | -1.77% |
Apr 4, 2024 | 299.90M | -0.13% |
Apr 3, 2024 | 300.30M | -1.96% |
Apr 2, 2024 | 306.30M | 4.33% |
Apr 1, 2024 | 293.60M | 5.01% |
Mar 28, 2024 | 279.60M | 3.06% |
Mar 27, 2024 | 271.30M | 0.82% |
Mar 26, 2024 | 269.10M | -3.55% |
Mar 25, 2024 | 279.00M | -3.23% |
Mar 22, 2024 | 288.30M | 1.09% |
Mar 21, 2024 | 285.20M | -0.35% |
Mar 20, 2024 | 286.20M | -2.32% |
Mar 19, 2024 | 293.00M | 0.10% |
Mar 18, 2024 | 292.70M | -4.35% |
Mar 15, 2024 | 306.00M | 2.14% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tevogen Bio Holdings | 304.54M |
Viemed Healthcare | 303.29M |
Spok Holdings | 302.25M |
ModivCare | 301.85M |
TScan Therapeutics | 297.39M |
Verrica Pharmaceuticals | 296.08M |
Terns Pharmaceuticals | 294.81M |
Vanda Pharmaceuticals | 294.02M |